Patrick Prevo, MD
Interventional Pain Medicine · Oklahoma City, OKNPI 1972770386
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,472 of the $4,091 with a category attached, or 60.4%. Medtronic accounts for 70.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $2,065 and has fallen 66.2% since, to $698 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in OK, where the typical reported total is $5,016.
Across 86 payments — averaging $47.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Nevro Corp.$246
- Abbott$238
- Trice Medical, Inc.$184
- Globus Medical$152
- Vertos Medical, Inc.$130
- plus $249 from 5 others
What the payments were for
- Travel & lodging$1,54438%
- Food & beverage$2,47260%
- Education$742%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 40 | $2,892 |
| Nevro Corp. | 11 | $246 |
| Abbott | 14 | $238 |
| Trice Medical, Inc. | 1 | $184 |
| Globus Medical | 7 | $152 |
| Vertos Medical, Inc. | 2 | $130 |
| SPR Therapeutics, Inc | 3 | $76 |
| Boston Scientific | 2 | $66 |
| Nalu Medical, Inc. | 4 | $54 |
| Curonix LLC | 1 | $30 |
| Relievant Medsystems, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,091 in reported general payments places this provider in the 40th percentile of 27 interventional pain medicine providers in Oklahoma.
See all interventional pain medicine providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 11 | $10,298 |
| Buprenorphine | 20 | $8,216 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 458 | $6,789 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 67 | $1,751 |
| Fentanyl | 13 | $826 |
| Gabapentin | 60 | $531 |
| Tizanidine Hcl | 34 | $500 |
| Pregabalin | 20 | $381 |
| Tramadol Hcl | 71 | $253 |
| Diclofenac Sodium | 19 | $190 |
| Nortriptyline Hcl | 25 | $181 |
| Methocarbamol | 15 | $151 |
| Cyclobenzaprine Hcl | 11 | $121 |
| Amitriptyline Hcl | 15 | $113 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Oklahoma City
- Brandon ValantineOklahoma City$9K
- Justin PorterOklahoma City$8K
- Blake ChristensenOklahoma City$6K
- Shawn EllisOklahoma City$6K
- Nathan OverbeyOklahoma City$5K
- Ahmed AmayemOklahoma City$5K
- Peyton JohnsonOklahoma City$5K
- Arthur BeachamOklahoma City$4K
- Timothy CramerOklahoma City$3K
- Sanaa KarimOklahoma City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.